Objectives 
Black and minority ethnic groups are commonly over-represented amongst those formally detained under mental health legislation, and this is most pronounced in secure forensic institutions. 1, 2 Research has shown differential representation of ethnic subgroups in the criminal justice process. Black adult males in the UK of African and Caribbean origin were imprisoned at 6.7 times the age-adjusted rate of white males in 1991. 3 African American men are estimated to be imprisoned at a rate six times that of white men. 4 Travellers are a small indigenous ethnic minority, documented as being part of Irish society for centuries. They have a long shared history and value system, which make them a distinct group. They have their own language, customs and traditions. The distinctive Traveller lifestyle and culture based on a nomadic tradition sets Travellers apart from the sedentary population or 'settled people'. 5 Travellers are widely acknowledged as one of the most marginalised and disadvantaged groups in Irish society. Travellers fare poorly on every indicator used to measure disadvantage: unemployment; poverty; social exclusion; health status; infant mortality; life expectancy; accommodation and living conditions. 6, 7 In Ireland, Travellers are recognised as a distinct group for census purposes and Pavee Point supported the proposal to include an ethnic question for all in the 2002 census. 8 The processes of stigmatisation and institutional disadvantage are of particular importance in psychiatry. Stigma can arise from and also contribute to mental disorders, leading to disadvantages in housing, employment and direct or indirect criminalisation. 9 Even those with non-psychiatric disorders such as epilepsy can find themselves over-represented in the criminal justice system if their illness is sufficiently stigmatising. 10 The opportunity to study processes of criminalisation in a discrete ethnic group who are not distinguished in the usual ways by colour or nationality is therefore instructive.
We hypothesised that if there is an excess of travellers admitted to the Central Mental Hospital, it is a passive reflection of the proportion of travellers committed to the Irish prison system.
Method
There are about 4,790 Traveller families or an estimated 21,158 Travellers in Ireland based on figures compiled by the Department of Environment and local housing authorities. 11, 12 This is an annual count of Traveller families in:
• Local authority or local authority assisted accommodation • On the roadside • Other private accommodation.
This figure is a more accurate estimate of the Traveller population than the 1996 population census figures, because it includes settled Travellers. The 1996 census showed that the Traveller community has a markedly different age and sex structure from that of the population in general. years, only 1.3% were over 65, and 49% were male. Travellers account for about 0.38% of the adult population. From these figures we calculate that there are 10,441 Travellers aged 15-65. There were 2,352,781 adults aged 15-65 in the total Irish population at the 1996 census.
A computerised case register of all admissions to the Central Mental Hospital for the three years 1997-1999 was compiled from a written register and cross-checked with ward admission records. During the study period, all transfers from the prisons to mental hospital in the State were to the Central Mental Hospital. There were 476 admissions of 352 individuals during the three-year period. Ethnicity was elicited from records and corroborated by consultation with staff to minimise the risk of under-estimation of Traveller numbers. Patients were classified as white European (to include European Union nationals but excluding Irish Travellers, thereby encompassing those not stigmatised by colour or ethnicity), black and other minority ethnic groups (to coincide with stigmatised groups) and Irish Travellers.
Discharge diagnosis was recorded for each patient according to the ICD-10 multi-axial system based on the multi-disciplinary team assessment and information from independent informants. No formal research instrument was in use.
The study of prison committals was carried out at Cloverhill Prison, the largest remand prison for the country, and the Dochas Centre Mountjoy Prison, the largest women's prison. All new committals were interviewed as part of the routine health screening of all individuals received at the prison, by a nurse and also by a researcher who was a post-membership psychiatrist. Ethnicity was elicited by self-definition. A history of drugs and alcohol problems was elicited by direct questioning for clinical purposes, to elicit those likely to require detoxification. As a check on the reliability of these selfreports, routine urine checks showed that of 86 reporting an opiate problem who had urine checks, 79 (92%) were positive. Those who did not have urine checks were previously known to the prison staff. Self-report on committal appears to be reliable for opiates and is likely to be reliable for alcohol and other substances.
There were 352 new committals to Cloverhill prison over the four weeks from October 9-November 5, 2000. New committals to Cloverhill Prison (154 male remands) were screened jointly by a researcher and a nurse employed by the prison service over this period. On 21 sampling days, chosen to be equivalent to three weeks continuous sampling, all new committals were jointly screened. None of those screened were committed twice during the study period. Similarly there were 146 new female committals during the six-week sampling period between October 2 and November 12, 2000. None was committed twice during the study period. On 21 days chosen to be equivalent to three weeks continuous sampling, 70 women were jointly screened.
Results

Admissions to the Central Mental Hospital
There were 28 admissions of Travellers, or 4.7% of the total 476 in the three years 1997-1999. Over the same period, there were 12 admissions (2.5% of total) of individu- Travellers compared to other admissions to the Central Mental Hospital had less severe mental illness than white Europeans, and more learning disability. Black and other ethnic minorities had a marked excess of severe mental illness when compared with other groups (see Table 1 ).
When the gravity of the offence for which the patient was imprisoned was compared across ethnic groups, no significant differences emerged.
Prison committals
Travellers accounted for 6% (95% CI 3-11) of male prison committals and 4% (95% CI 2-12) of female committals (see Table 2 ). The annualised committal rate for male Travellers was 2.8% (95% CI 2.4-3.3) of all adult male Travellers in Ireland and 1% for adult female Travellers (95% CI 0.8-1.3). Male Travellers had a relative risk of imprisonment compared to the settled community of 17.4 (95% CI 2.3-131.4), 12.9 for female Travellers (95% CI 1.7-96.7) (see Table 3 ).
Comparing remanded male Travellers with remanded white Europeans (ie. from within the EU), for self-reported drugs and alcohol problems combined (see Table 4 ), imprisoned Travellers are significantly more likely to report problems with drugs and alcohol (relative risk 1.46, 95% CI 1.11-1.9).
Discussion
The ethnicity of all new committals to Cloverhill
Prison was elicited by self-definition in this study. Detection of psychiatric illness may have been hampered by the lack of a standardised screening tool for diagnosis of illness. The environment in which screening took place in the prison did not afford privacy and confidentiality to prisoners. This may have resulted in inadequate disclosure of illness to the researchers. We have therefore only reported the discharge diagnosis for those admitted to the Central Mental Hospital.
Our study confirms our original hypotheses that Irish Travellers, as an ethnic group, represent a disproportionate number of those admitted to the Central Mental Hospital and that both male and female Travellers have significantly higher prison committal rates than the general population. This over-representation might be an artefact if the number of Travellers in the adult population is substantially underestimated, but this would require approximately 95% of Travellers to have been missed in population estimates, and Travellers would have to account for almost 7% of the adult population. Our findings are similar to studies of ethnic minorities in other jurisdictions and highlight the differential representation of minority ethnic groups in the criminal justice process.
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Heron et al report that Traveller women have high levels of psychological distress, higher in those with the worst accommodation and environmental facilities.
14 Travellers admitted to the Central Mental Hospital had less severe mental illness than white Europeans, and more learning disability. This distinguishes them from other ethnic minorities in the same series who showed a marked excess of severe mental illness when compared with white Europeans.
Imprisoned Travellers are significantly more likely to report problems with drugs and alcohol. Self-report is a soft measure, but it is a reflection of willingness to accept treatment. This does not prove that all Travellers as a group have a higher prevalence of drugs and alcohol problems, but it suggests that they may be more likely than the settled population to be imprisoned if they have a drugs or alcohol problem. This may reflect the difficulties Travellers experience in accessing drug and alcohol services.
Travellers show a high utilisation of general practitioner and accident and emergency services, and a low utilisation of other hospital services including aftercare, preventive services and specialised services such as psychiatric care. Low levels of literacy and a nomadic lifestyle have been identified as barriers to Travellers gaining access to the health services.
Prejudice on the part of the general public and service providers may also result in Travellers being refused access to health services. 15 Little is known concerning the extent to which Travellers are over or under-represented in general adult psychiatric services. Less is known regarding the true prevalence of mental illnesses in the Traveller population.
The systematic induction into prison of a significant proportion of any identifiable group within society is a cause for concern. From a mental health perspective, prisoners have an increased risk of suicide. [16] [17] [18] And prisoners have more mental health problems than the general population. 19 Use of injected drugs and infection with hepatitis C and other viruses are endemic in Irish prisons, and only a small number of first time prison entrants were infected with one or more of the blood-borne viruses. 13 Imprisonment disrupts work, education, marriage and parenting in ways that are harmful to the prisoner and to the prisoner's family. 20 In any ethnic group or sub-population where imprisonment is so common, it is reasonable to hypothesise for future research that the lowered life expectancy, the impaired physical and mental health, may to some extent be caused by imprisonment itself.
A practical consequence would be to use contact with the criminal justice system as a means of engaging individuals in culture-specific programmes for health promotion, examples of which can be found in other jurisdictions. In Canada, 21 Australia and New Zealand, 22, 23 indigenous minorities are also over-represented in prisons and forensic psychiatric institutions. Approaches to specific services 24 and training 25 have been described and should be considered in the Irish mental health services and also in the Irish courts and prison service.
Declaration of Interest: None.
